Abstract
The action of various concentrations of levamisole on normal human lymphocytes was investigated in vitro. The action of levamisole (10(-1) mg-10(-8) mg%) upon rosette formation was studied using two rosette assays with SRBC (the active and the total T-rosette tests) to quantify T cells and the EAC assay to quantify B cells. Levamisole at only 10(-3) mg% significantly increased the percentage of both active and total T cells. In sharp contrast, levamisole between 10(-2) and 10(-7) mg% significantly decreased the EAC percentage. It is concluded that levamisole promotes a better expressivity of T-cell receptor and decreases the expressivity of C3 receptor.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Chisholm R. L., Tubergen D. G. The significance of varying SRBC/lymphocyte ratio in T cell rosette formation. J Immunol. 1976 May;116(5):1397–1399. [PubMed] [Google Scholar]
- Felsburg P. J., Edelman R., Bilman R. H. The active E rosette test: correlation with delayed cutaneous hypersensitivity. J Immunol. 1976 Apr;116(4):1110–1114. [PubMed] [Google Scholar]
- Galant S. P., Remo R. A. Beta-adrenergic inhibition of human T lymphocyte rosettes. J Immunol. 1975 Jan;114(1 Pt 2):512–513. [PubMed] [Google Scholar]
- Hadden J. W., Coffey R. G., Hadden E. M., Lopez-Corrales E., Sunshine G. H. Effects of levamisole and imidazole on lymphocyte proliferation and cyclic nucleotide levels. Cell Immunol. 1975 Nov;20(1):98–103. doi: 10.1016/0008-8749(75)90088-x. [DOI] [PubMed] [Google Scholar]
- Renoux G., Renoux M. Antigenic competition and nonspecific immunity after a rickettsial infection in mice: restoration of antibacterial immunity by phenyl-imidothiazole treatment. J Immunol. 1972 Oct;109(4):761–765. [PubMed] [Google Scholar]
- Sampson D., Lui A. The effect of levamisole on cell-mediated immunity and suppressor cell function. Cancer Res. 1976 Mar;36(3):952–955. [PubMed] [Google Scholar]
- Szpilman H., Luft S., Glińska-Urban D., Fischer W., Plachecka M. Levamisole and cell-mediated immunity and serum-immunoglobulins in rheumatoid arthritis. Lancet. 1976 Jul 24;2(7978):208–209. doi: 10.1016/s0140-6736(76)92393-x. [DOI] [PubMed] [Google Scholar]
- Wybran J., Chantler S., Fudenberg H. H. Isolation of normal T cells in chronic lymphatic leukaemia. Lancet. 1973 Jan 20;1(7795):126–129. doi: 10.1016/s0140-6736(73)90196-7. [DOI] [PubMed] [Google Scholar]
- Wybran J., Fudenberg H. H. Thymus-derived rosette-forming cells in various human disease states: cancer, lymphoma, bacterial and viral infections, and other diseases. J Clin Invest. 1973 May;52(5):1026–1032. doi: 10.1172/JCI107267. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wybran J., Fudenberg H. H. Thymus-derived rosette-forming cells. N Engl J Med. 1973 May 17;288(20):1072–1073. doi: 10.1056/NEJM197305172882011. [DOI] [PubMed] [Google Scholar]
- van Ginckel R. F., Hoebeke J. Effects of levamisole on spontaneous rosette-forming cells in murine spleen. Eur J Immunol. 1976 Apr;6(4):305–307. doi: 10.1002/eji.1830060414. [DOI] [PubMed] [Google Scholar]